Jpmorgan Chase & CO Opko Health, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Opko Health, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,501,332 shares of OPK stock, worth $3.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,501,332
Previous 1,574,971 58.82%
Holding current value
$3.78 Million
Previous $2.32 Million 79.35%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$1.45 - $1.94 $1.34 Million - $1.8 Million
926,361 Added 58.82%
2,501,332 $4.15 Million
Q4 2024

Feb 12, 2025
SELL
$1.4 - $1.64 $366,655 - $429,511
-261,897 Reduced 14.26%
1,574,971 $2.32 Million
Q3 2024

Dec 26, 2024
BUY
$1.21 - $1.68 $649,801 - $902,203
537,026 Added 41.31%
1,836,868 $2.74 Million
Q3 2024

Nov 08, 2024
BUY
$1.21 - $1.68 $649,801 - $902,203
537,026 Added 41.31%
1,836,868 $2.74 Million
Q2 2024

Dec 26, 2024
SELL
$1.21 - $1.42 $649,801 - $762,576
-537,026 Reduced 29.24%
1,299,842 $1.62 Million
Q2 2024

Aug 12, 2024
SELL
$1.21 - $1.42 $354,180 - $415,649
-292,711 Reduced 18.38%
1,299,842 $1.62 Million
Q1 2024

Dec 26, 2024
SELL
$0.87 - $1.57 $212,554 - $383,574
-244,315 Reduced 13.3%
1,592,553 $1.91 Million
Q1 2024

May 10, 2024
SELL
$0.87 - $1.57 $306,052 - $552,300
-351,784 Reduced 18.09%
1,592,553 $1.91 Million
Q4 2023

Dec 26, 2024
BUY
$1.23 - $1.63 $132,186 - $175,174
107,469 Added 5.85%
1,944,337 $2.94 Million
Q4 2023

Feb 12, 2024
BUY
$1.23 - $1.63 $63,958 - $84,758
51,999 Added 2.75%
1,944,337 $2.94 Million
Q3 2023

Nov 14, 2023
SELL
$1.5 - $2.17 $754,024 - $1.09 Million
-502,683 Reduced 20.99%
1,892,338 $3.03 Million
Q2 2023

Aug 11, 2023
BUY
$1.37 - $2.17 $1.55 Million - $2.45 Million
1,129,821 Added 89.3%
2,395,021 $5.2 Million
Q1 2023

May 18, 2023
BUY
$1.06 - $1.61 $540,443 - $820,861
509,852 Added 67.5%
1,265,200 $1.85 Million
Q1 2023

May 11, 2023
SELL
$1.06 - $1.61 $554,878 - $842,786
-523,470 Reduced 40.93%
755,348 $1.1 Million
Q4 2022

Feb 13, 2023
SELL
$1.05 - $2.01 $1.15 Million - $2.2 Million
-1,095,358 Reduced 46.14%
1,278,818 $1.6 Million
Q3 2022

Nov 14, 2022
BUY
$1.81 - $2.81 $623,930 - $968,643
344,713 Added 16.99%
2,374,176 $4.49 Million
Q2 2022

Aug 11, 2022
SELL
$2.33 - $3.61 $1.51 Million - $2.33 Million
-646,680 Reduced 24.16%
2,029,463 $5.13 Million
Q1 2022

May 11, 2022
BUY
$2.87 - $4.93 $1.33 Million - $2.28 Million
463,047 Added 20.92%
2,676,143 $9.21 Million
Q4 2021

Feb 10, 2022
BUY
$3.52 - $5.15 $3.3 Million - $4.82 Million
936,522 Added 73.36%
2,213,096 $10.6 Million
Q3 2021

Nov 12, 2021
BUY
$3.44 - $4.24 $4.39 Million - $5.41 Million
1,276,574 New
1,276,574 $4.66 Million

Others Institutions Holding OPK

# of Institutions
240
Shares Held
206M
Call Options Held
1.49M
Put Options Held
332K
View Full List

About OPKO HEALTH, INC.

OPK Quotes by TradingView
  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.17B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email